RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer
about
Identification and characterization of novel human tissue-specific RFX transcription factorsRole for RFX transcription factors in non-neuronal cell-specific inactivation of the microtubule-associated protein MAP1A promoterRFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdomDimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains.Induction of Myc-intron-binding polypeptides MIBP1 and RFX1 during retinoic acid-mediated differentiation of haemopoietic cellsFunction of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-YSpecific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5En masse nascent transcription analysis to elucidate regulatory transcription factors.RFX1, a single DNA-binding protein with a split dimerization domain, generates alternative complexesNuclear import and DNA-binding activity of RFX1The transcription factor regulatory factor X1 increases the expression of neuronal glutamate transporter type 3.The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5Regulation of FGF1 gene promoter through transcription factor RFX1.The RFX protein RfxA is an essential regulator of growth and morphogenesis in Penicillium marneffei.Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome.p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activityEnhancer I predominance in hepatitis B virus gene expression.Sequence-independent inhibition of RNA transcription by DNA dumbbells and other decoys.DNA binding properties of a chemically synthesized DNA binding domain of hRFX1.Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter.FRESCo: finding regions of excess synonymous constraint in diverse virusesRetinoid X receptor alpha transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor.Interactions of the transcription factors MIBP1 and RFX1 with the EP element of the hepatitis B virus enhancer.Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.Solution NMR structure of the C-terminal domain of the human protein DEK.The myc intron-binding polypeptide associates with RFX1 in vivo and binds to the major histocompatibility complex class II promoter region, to the hepatitis B virus enhancer, and to regulatory regions of several distinct viral genes.A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity.Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations.Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues.Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II.Unbiased discovery of interactions at a control locus driving expression of the cancer-specific therapeutic and diagnostic target, mesothelin.The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities.Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactionsIncreasing binding of a transcription factor immediately downstream of the cap site of a cytomegalovirus gene represses expression.HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.A mutation in the 5' untranslated region of the human alpha-galactosidase A gene in high-activity variants inhibits specific protein binding.RFX1 mediates the serum-induced immediate early response of Id2 gene expression.Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation.
P2860
Q21093412-3E2F1F7C-E1E3-443A-8B31-D01B903C1620Q24314851-7F3057C8-C3A4-4E2D-B068-600A0C08D0D0Q24322587-746EB37C-30E6-4AA0-9117-3F06C1F58278Q24517594-C1B0749A-D761-48C6-B84E-0705682C4E51Q24531925-AFE8B122-DA84-434C-A274-D7488221B253Q24562002-63F6326C-307E-43A2-B610-6C2B282E8756Q24683275-5B62FD73-76C8-48EA-B426-7651CD290D06Q25255974-507552D6-6EFE-412B-A7E0-690341DCB536Q28281985-98F1575A-7B91-4A8D-8905-14521B615353Q29028339-8E0EF2B5-A9B9-4D32-94D0-DC79ACC61C6FQ30440563-6C2D4F77-3A25-4692-BA84-0FA4D9B3B79DQ33787243-F31A3F80-EF46-4B2D-8806-4A8019BBBC5FQ33810146-3867EBE2-26E1-47C6-9871-8B806B2BE1CCQ33825777-29E33A61-9ECE-45C0-AD05-8461CC9DBCBFQ33833777-49FEE576-7966-4169-9EB1-D03518D4F1AFQ33888115-E8AD6E7D-9AFA-4B50-BE4C-07EAE9DE792FQ33981411-13032E7A-7F06-472E-AA9C-9B19966FBD25Q34293368-F727227A-637B-412D-9420-A5A680BC9FD0Q34625391-7BAC4D25-B162-4337-8FC0-22FC6F0A7A26Q34663414-3BF16E81-E9C1-4362-844B-C58B86550812Q34772795-BC27DFFC-49A7-4B76-A8DC-30B35A298D9DQ35223162-0869055F-8BEC-42D8-8DEF-FE99851F8944Q35830442-C7B96D2E-C9FD-4567-BAFA-FB6E810443BAQ35868069-EE1A2801-BEFE-4F4B-B3C4-AA4B6D8C423EQ36363840-FB5A7A2F-0485-478E-9135-D8575CA0EFB7Q36519194-32D2362A-3DA6-424A-98BE-C3E8B648ED0BQ36551303-C8D80D81-ECA9-4F9A-99F5-BD500BB7295AQ36561642-C949E17F-936F-49BB-8319-65EDB2297939Q36631647-D6EB884E-D553-454B-A530-E81E7708CB7DQ36667891-EC80F408-050E-4BEE-8F72-54171A8BF80AQ37693480-569CDC55-A3AD-4462-A50B-F245E51643CEQ38356053-560F9CA5-8F2D-4EB9-815E-F3FDBD690DB1Q39268512-32AF621E-36AA-4A40-AA04-B96D3B6DB1BFQ39453564-AF7B0631-78A3-4B74-AFE4-C47E1702922DQ40019686-0EA5D83B-A7AD-4EF5-AC8F-DCF53A87F8D2Q40395256-DD1E6532-5462-4706-B3D1-7FADD44D3855Q40771342-C5C45FBE-5AEC-44BF-8250-8F92C7C8FE7CQ41297319-5EC59729-462C-469E-95DA-484A31AA78E5Q42826566-0BB2FE98-0C81-40C5-B81D-F76568C4CD0DQ42828596-4945845B-1AE4-4C75-B03E-848520FB3F3D
P2860
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer
description
1993 nî lūn-bûn
@nan
1993 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@ast
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@en
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@nl
type
label
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@ast
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@en
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@nl
prefLabel
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@ast
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@en
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@nl
P2093
P2860
P356
P1476
RFX1 is identical to enhancer ...... the hepatitis B virus enhancer
@en
P2093
P2860
P304
P356
10.1128/MCB.13.10.6375
P407
P577
1993-10-01T00:00:00Z